- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.35 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 9 residues within 4Å:- Chain A: L.57, G.58, E.61, G.140, P.141, T.157, L.238, R.256
- Chain B: K.77
Ligand excluded by PLIPEDO.3: 7 residues within 4Å:- Chain A: Y.56, K.59, L.60, E.63, L.242, K.245, H.246
Ligand excluded by PLIPEDO.4: 9 residues within 4Å:- Chain A: A.116, L.119, A.120, L.123, C.162, I.227, W.231
- Ligands: EDO.5, EDO.6
Ligand excluded by PLIPEDO.5: 11 residues within 4Å:- Chain A: M.90, A.116, A.120, F.198, I.219, L.221, D.222, W.225, I.227, W.231
- Ligands: EDO.4
Ligand excluded by PLIPEDO.6: 12 residues within 4Å:- Chain A: A.116, L.119, N.160, F.161, C.162, F.198, V.215, W.231, G.233, A.234
- Ligands: EDO.4, EDO.9
Ligand excluded by PLIPEDO.7: 9 residues within 4Å:- Chain A: L.84, I.87, E.88, I.92, D.93, N.94, T.96, S.99, I.102
Ligand excluded by PLIPEDO.8: 7 residues within 4Å:- Chain A: M.196, V.197, F.198, G.199, I.219, P.220, L.221
Ligand excluded by PLIPEDO.9: 11 residues within 4Å:- Chain A: M.114, L.115, A.116, R.144, M.158, N.160, F.198, G.235
- Ligands: ANP.1, EDO.6, AXZ.24
Ligand excluded by PLIPEDO.10: 7 residues within 4Å:- Chain A: R.170, D.200, T.201, L.202, A.214, V.215, V.216
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: E.54, K.59, R.62, E.63
- Chain B: R.66
- Ligands: EDO.15
Ligand excluded by PLIPEDO.12: 8 residues within 4Å:- Chain A: K.150, H.206, L.209, K.243, V.244, D.247, F.248, K.249
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: G.72, F.73, K.135
- Chain B: Y.49, A.50, R.53
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain A: G.165, S.166, G.167, C.168, T.169, P.230
Ligand excluded by PLIPEDO.15: 3 residues within 4Å:- Chain A: E.52, K.59
- Ligands: EDO.11
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain A: R.11, V.14, S.259, Y.260, S.265, T.266, N.267
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain A: L.153, E.154, E.155, K.252, A.255
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: S.35, L.38, S.39, K.42, H.270
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain A: R.71, F.73, K.135, Q.163, N.172, I.176
Ligand excluded by PLIPEDO.20: 13 residues within 4Å:- Chain A: N.55, Y.56, L.57, L.242, F.248, R.253, A.254, A.255, Y.260, Y.261, N.262, G.263
- Chain B: K.77
Ligand excluded by PLIPEDO.21: 8 residues within 4Å:- Chain A: E.151, H.152, M.205, D.208, L.209, E.210, R.240
- Ligands: ANP.1
Ligand excluded by PLIPEDO.27: 9 residues within 4Å:- Chain A: K.77
- Chain B: L.57, G.58, E.61, G.140, P.141, T.157, L.238, R.256
Ligand excluded by PLIPEDO.28: 7 residues within 4Å:- Chain B: Y.56, K.59, L.60, E.63, L.242, K.245, H.246
Ligand excluded by PLIPEDO.29: 9 residues within 4Å:- Chain B: A.116, L.119, A.120, L.123, C.162, I.227, W.231
- Ligands: EDO.30, EDO.31
Ligand excluded by PLIPEDO.30: 11 residues within 4Å:- Chain B: M.90, A.116, A.120, F.198, I.219, L.221, D.222, W.225, I.227, W.231
- Ligands: EDO.29
Ligand excluded by PLIPEDO.31: 12 residues within 4Å:- Chain B: A.116, L.119, N.160, F.161, C.162, F.198, V.215, W.231, G.233, A.234
- Ligands: EDO.29, EDO.34
Ligand excluded by PLIPEDO.32: 9 residues within 4Å:- Chain B: L.84, I.87, E.88, I.92, D.93, N.94, T.96, S.99, I.102
Ligand excluded by PLIPEDO.33: 7 residues within 4Å:- Chain B: M.196, V.197, F.198, G.199, I.219, P.220, L.221
Ligand excluded by PLIPEDO.34: 11 residues within 4Å:- Chain B: M.114, L.115, A.116, R.144, M.158, N.160, F.198, G.235
- Ligands: ANP.26, EDO.31, AXZ.49
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain B: R.170, D.200, T.201, L.202, A.214, V.215, V.216
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain A: R.66
- Chain B: E.54, K.59, R.62, E.63
- Ligands: EDO.40
Ligand excluded by PLIPEDO.37: 8 residues within 4Å:- Chain B: K.150, H.206, L.209, K.243, V.244, D.247, F.248, K.249
Ligand excluded by PLIPEDO.38: 6 residues within 4Å:- Chain A: Y.49, A.50, R.53
- Chain B: G.72, F.73, K.135
Ligand excluded by PLIPEDO.39: 6 residues within 4Å:- Chain B: G.165, S.166, G.167, C.168, T.169, P.230
Ligand excluded by PLIPEDO.40: 3 residues within 4Å:- Chain B: E.52, K.59
- Ligands: EDO.36
Ligand excluded by PLIPEDO.41: 7 residues within 4Å:- Chain B: R.11, V.14, S.259, Y.260, S.265, T.266, N.267
Ligand excluded by PLIPEDO.42: 5 residues within 4Å:- Chain B: L.153, E.154, E.155, K.252, A.255
Ligand excluded by PLIPEDO.43: 5 residues within 4Å:- Chain B: S.35, L.38, S.39, K.42, H.270
Ligand excluded by PLIPEDO.44: 6 residues within 4Å:- Chain B: R.71, F.73, K.135, Q.163, N.172, I.176
Ligand excluded by PLIPEDO.45: 13 residues within 4Å:- Chain A: K.77
- Chain B: N.55, Y.56, L.57, L.242, F.248, R.253, A.254, A.255, Y.260, Y.261, N.262, G.263
Ligand excluded by PLIPEDO.46: 8 residues within 4Å:- Chain B: E.151, H.152, M.205, D.208, L.209, E.210, R.240
- Ligands: ANP.26
Ligand excluded by PLIP- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.22: 3 residues within 4Å:- Chain A: E.210, S.213
- Ligands: ANP.1
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.210, A:S.213, H2O.4, H2O.5
MG.23: 4 residues within 4Å:- Chain A: Q.101, R.144, H.152
- Ligands: ANP.1
No protein-ligand interaction detected (PLIP)MG.47: 3 residues within 4Å:- Chain B: E.210, S.213
- Ligands: ANP.26
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:E.210, B:S.213, H2O.9, H2O.9
MG.48: 4 residues within 4Å:- Chain B: Q.101, R.144, H.152
- Ligands: ANP.26
No protein-ligand interaction detected (PLIP)- 2 x AXZ: 2-{[DIHYDROXY(4-AMINOETHYLPHENYL)-{4}-SULFANYL]AMINO}-3-HYDROXYPROPANOIC ACID(Non-covalent)
AXZ.24: 15 residues within 4Å:- Chain A: I.87, I.92, L.98, S.99, Q.101, I.102, P.113, M.114, R.144, C.195, M.196, V.197, F.198
- Ligands: ANP.1, EDO.9
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:I.92, A:L.98, A:Q.101, A:I.102, A:P.113, A:P.113
- Hydrogen bonds: A:R.144, A:M.196, A:V.197
- Water bridges: A:R.144
AXZ.49: 15 residues within 4Å:- Chain B: I.87, I.92, L.98, S.99, Q.101, I.102, P.113, M.114, R.144, C.195, M.196, V.197, F.198
- Ligands: ANP.26, EDO.34
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:I.92, B:L.98, B:Q.101, B:I.102, B:P.113, B:P.113
- Hydrogen bonds: B:R.144, B:M.196, B:V.197
- Water bridges: B:R.144
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.25: 5 residues within 4Å:- Chain A: R.124, K.125, R.128
- Chain B: N.267, H.269
5 PLIP interactions:5 interactions with chain A- Water bridges: A:N.121, A:K.125
- Salt bridges: A:R.124, A:K.125, A:R.128
PO4.50: 5 residues within 4Å:- Chain A: N.267, H.269
- Chain B: R.124, K.125, R.128
5 PLIP interactions:5 interactions with chain B- Water bridges: B:N.121, B:K.125
- Salt bridges: B:R.124, B:K.125, B:R.128
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schmidt, M.J. et al., Structural Basis of Furan-Amino Acid Recognition by a Polyspecific Aminoacyl-tRNA-Synthetase and its Genetic Encoding in Human Cells. Chembiochem (2014)
- Release Date
- 2014-04-30
- Peptides
- PYRROLYSYL-TRNA SYNTHETASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.35 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 2 x AXZ: 2-{[DIHYDROXY(4-AMINOETHYLPHENYL)-{4}-SULFANYL]AMINO}-3-HYDROXYPROPANOIC ACID(Non-covalent)
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schmidt, M.J. et al., Structural Basis of Furan-Amino Acid Recognition by a Polyspecific Aminoacyl-tRNA-Synthetase and its Genetic Encoding in Human Cells. Chembiochem (2014)
- Release Date
- 2014-04-30
- Peptides
- PYRROLYSYL-TRNA SYNTHETASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A